Endocrine Abstracts

The use of high doses of the ergot-derived dopamine receptor agonists such as cabergoline for treatment of Parkinson’s disease has been associated with increased prevalence of echocardiography detected cardiac valve disease. Whether smaller doses of cabergoline used for treating endocrine disorders causes similar valvular abnormalities is not yet conclusively established.We conducted echocardiographic screening of 35 adult endocrine patients on curr...